http://ADPHARMA.NET
ADPHARMACEUTICALS1 5847dbd200671109b8397d6c False 300 20
OK
background image not found
Found results for
'primary target'
Cernos Gel 1% (Testosterone Gel) INR   0 INR  0
-NaN%

Cernos Gel 1% (Testosterone Gel)

Cernos Gel 1% (Testosterone) is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired): testicular failure due to conditions such as cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range. Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. These men have low testosterone serum concentrations, but have gonadotropins in the normal or low range. Cernos 1% w/w gel is used in the treatment of male hypogonadism. It treats the symptoms of low testosterone such as decreased sexual desire and ability, extreme tiredness, low energy, depression, and loss of certain male characteristics such as muscular build and deep voice. How cernos gel works. Cernos 1% w/w gel works by replacing testosterone that is normally produced in the body. Common side effects of cernos gel application site reactions (burning, irritation, itching and redness), Headache, Acne, Increased blood pressure.

INR 0 INR 0

Availability:False

Pay mode:COD only

view details
Hepcinat - LP INR   0 INR  0
-NaN%

Hepcinat - LP

We are pioneer supplier of Hepcinat to Russia. HEPCINAT-LP contains polymerase inhibitors which called sofosbuvir and ledipasvir . Hepcinat-LP manufactured by Natco Pharma and approved for treatment of patients infected with Hepatitis C (HCV genotypes 1 and 4). Sofosbuvir & Ledipasvir is FDA-approved and EASL recommended treatment protocol for HCV, which does not include interferon or ribavirin. The clinical trials have proven very high success rate of sofosbuvir in combination with ledipasvir. Hepcinat-LP Tablets is a formulation combination of anti-viral medications Ledipasvir and Sofosbuvir used in the treatment of Chronic Hepatitis C Virus (CHCV) infection genotype 1. Hepcinat-LP is a prescription medicine containing Ledipasvir (90mg) a viral NS5A inhibitor and Sofosbuvir (400mg) a nucleotide inhibitor of the viral RNA polymerase. In one of official clinical trials involved more than 1,600 people with HCV genotype 1. The course of treatment was only 84 days. By the end of therapy 1556 patients achieved the primary target – absence of the virus. Adverse events that occurred in patients receiving sofosbuvir together with ledipasvir were mild and generally accompanied by headache and fatigue. Working pattern: Sofosbuvir+ledipasvir targetly affects to specific proteins involved in viral replication and thus totally stop the disease.

INR 0 INR 0

Availability:True

Pay mode:COD only

view details
1
false